Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,457,249
-$237,379 QoQ
Shares Held
60,517
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,106
of 2,821 holders
Holding Since
Mar 2020
22 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. PFE ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
This page
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
|
6,543 | $1,240,683 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,457,249 | 60,517 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,694,628 | 60,350 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,051,551 | 42,231 | Shares | Sole | 2026-02-18 | |
| 2024-12-31 | $351,787 | 13,260 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $428,051 | 14,791 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $405,989 | 14,510 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,345,736 | 48,495 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,699,811 | 93,776 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,999,496 | 90,428 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $7,834,114 | 213,580 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $13,748,457 | 336,972 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $17,148,337 | 334,667 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $15,411,878 | 352,191 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,345,778 | 368,983 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $21,822,711 | 421,532 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $10,239,388 | 173,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,803,192 | 158,177 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,585,724 | 91,566 | Shares | Sole | 2022-01-28 | |
| 2020-12-31 | $206,136 | 5,600 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,673,629 | 72,851 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,364,964 | 72,323 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,195,657 | 67,269 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||